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The details of a synthesis method for biologically relevant
hydrated calcium pyrophosphates (CPPs, Ca2P2O7·nH2O) has
been elucidated. Control of the pH (from 3.6 to 5.8) and the
temperature (from 25 to 90 °C) during the synthesis enabled
the preparation of four pure CPP phases within one hour
without intermediates: monoclinic and triclinic calcium pyro-
phosphate dihydrate (CPPD, Ca2P2O7·2H2O), which are the
two CPP phases detected in vivo in joints of arthritic patients,
monoclinic tetrahydrate β (CPPT, Ca2P2O7·4H2O) and an
amorphous phase (a-CPP, Ca2P2O7·nH2O). Four domains cor-
responding to the four different phases of hydrated calcium
pyrophosphate were identified; a-CPP was synthesised over
a very wide pH and temperature range (up to 90 °C) within
the domain of synthesis conditions explored, including physi-
ological conditions (pH 7.4 and 37 °C). The as-synthesised
hydrated CPP phases were characterised by complementary
techniques (powder X-ray diffraction, FTIR and Raman spec-
troscopy, scanning electron microscopy and thermogravime-
try) and chemical analyses. Rietveld refinement analyses of
the as-synthesised crystalline phases were performed, and
Introduction
Calcium pyrophosphate hydrates (CPP, Ca2P2O7·nH2O)
are involved in several forms of arthritis, including calcium
pyrophosphate crystal deposition disease, also known as
pseudogout, and osteoarthritis (OA), the most frequent
form of rheumatic disease.[1,2] To date, two different poly-
morphs of dihydrate CPP crystals are commonly identified
in joint tissues of arthritic patients: monoclinic and triclinic
calcium pyrophosphate dihydrate (CPPD, Ca2P2O7·2H2O)
crystals, referred to as m-CPPD and t-CPPD, respectively.
They have been reported in a large range of sizes, typically
from 0.06 to 0.3 μm in the temporomandibular joint and
from ca. 1 to 20 μm in the knee.[3,4] They both appear to
induce an inflammatory response, possibly because of the
rupture of lysosome phospholipid membranes induced by
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there were significant differences between the m-CPPD X-
ray diffraction pattern observed and previously published
cell parameters. Vibrational spectroscopy allowed the crys-
talline and amorphous phases synthesised to be clearly dis-
tinguished and identified owing to the high flexibility of the
pyrophosphate anion. Chemical analyses showed that the
synthesis conditions used in this study did not allow signifi-
cant hydrolysis of the pyrophosphate ions into phosphate
ions, and the number of water molecules associated with
each synthesised CPP phase was determined by thermogravi-
metric analysis. Different mechanisms of dehydration were
also identified. The study of the formation of synthetic and
well-characterised hydrated calcium pyrophosphate phases
and their availability in large amounts in vitro could allow
progress to be made on the biological role of these phases
and their possible transformations. This could also aid their
detection in patients suffering from disease caused by cal-
cium salt crystals and could clarify the mechanism by which
CPP crystals form and evolve in vivo.
pyrophosphate groups on the surface of the crystals.[5–8]
However, current treatments cannot inhibit the formation
of CPP crystals, although they help to resolve the inflam-
matory responses.[9–11]
Although many papers have focused on CPP crystals as-
sociated with OA from a clinical point of view, very little in
the way of physicochemical data on these phases of bio-
logical interest has been published. Several in vitro synthe-
ses of hydrated CPP have been reported.[12–20] They were
mainly based on the method developed by Brown et al.[12]
and its modifications by Mandel et al.[13] Four calcium py-
rophosphate hydrates were reported among the 25 calcium-
containing pyrophosphate compounds described in the lit-
erature,[12] including m-CPPD, t-CPPD, a dimorphic mono-
clinic tetrahydrate (CPPT, Ca2P2O7·4H2O) referred to as m-
CPPT α and m-CPPT β.[21,22]
However, these methods present some drawbacks as they
lead to low total reaction yields and generally involve un-
stable calcium pyrophosphate intermediates, as highlighted
by Groves et al.[20] Other methods were developed to over-
come either or both of these disadvantages, especially for
the synthesis of t-CPPD, m-CPPT β and an amorphous
phase (a-CPP), but not for m-CPPD.[20,23,24] However, the
crystalline phases are obtained with synthesis durations be-
tween two hours and one week, and the reproducibility of
some of these methods is rather unpredictable and the pure
phases are not always obtained.[25,26] There is an interest in
studying the conditions of formation of all these hydrated
CPP phases in vitro and in finely characterising them to
better understand their formation in vivo (direct formation
or possibly the hydrolysis and evolution of a metastable pre-
cursor phase). We recently reported the synthesis of m-
CPPT β at pH 4.6 and 25 °C by a fast and simple synthesis
method.[27] On the basis of this synthesis method, we could
suggest that a variation of pH and temperature leads to the
formation of pure pathological CPP phases, that is m-
CPPD and t-CPPD.
In the present study, we investigated the formation condi-
tions of hydrated calcium pyrophosphate phases obtained
by a single-step precipitation in aqueous media. The four
different forms obtained, m-CPPD, t-CPPD, m-CPPT β
and a-CPP, were characterised by physicochemical methods
and techniques including powder X-ray diffraction (XRD),
FTIR and Raman spectroscopy, thermogravimetric and
differential thermal analyses (TGA-DTA), scanning elec-
tron microscopy (SEM), the Brunauer–Emmett–Teller
(BET) method for specific surface area determination and
chemical analyses (calcium and phosphate titration).
Results and Discussion
Synthesis
The synthesis method implemented in the present study
could be described as a direct (without intermediates) syn-
thesis method for several hydrated calcium pyrophosphate
phases. The double decomposition of the calcium nitrate
and potassium pyrophosphate solutions occurs in an aque-
ous buffered medium containing ammonium and acetate
ions. The precipitation reaction involved can be represented
by Equation (1).
2Ca2+ + P2O74– Ca2P2O7·nH2O (1)
Generally, the two most important parameters involved
in the precipitation of various salts in different hydration
states are temperature and pH. Our study focuses on the
influence of these parameters, which were not systemati-
cally explored and described in previous works related to
CPP synthesis. Although other parameters, such as stirring
or reagent concentration, may determine the nature of the
phases formed, most of our syntheses were performed with
a stoichiometric calcium/pyrophosphate ratio of 2 and with
magnetic stirring. Briefly, we investigated the influence of
the method of addition of reagents into the buffer, espe-
cially the influence of concentration of the reagent solu-
tions.
The influence of pH and temperature was studied by per-
forming several experiments with pH varied from 3.6 to 5.8
and temperature varied from 25 to 90 °C at fixed concentra-
tions. Samples from these experiments were analysed by
FTIR spectroscopy and powder XRD (data not shown) and
compared with data already published.[12,13,22,24,28]
Figure 1 shows the formation domains of pure hydrated
CPP phases for our synthesis method. At fixed concentra-
tions of pyrophosphate and calcium (75 and 150 mmol L–1,
respectively, in reagent solution), we determined four do-
mains corresponding to four different phases of hydrated
calcium pyrophosphate: a-CPP, an amorphous phase, m-
CPPT β, a tetrahydrated phase, both formed at low tem-
peratures, and m-CPPD and t-CPPD, two biologically rel-
evant phases synthesised at higher temperatures (Figure 1).
Mixtures of these phases (generally two CPP phases, includ-
ing a-CPP and poorly crystalline phases for pH above 4.5
and temperature under 70 °C) were obtained under pH and
temperature conditions corresponding to the areas between
the domains of pure CPP formation.
Figure 1. Synthesis domains of the four pure hydrated CPP phases.
Mixtures of these phases were obtained under conditions outside
these domains.
The CPP crystalline compounds synthesised under these
conditions have coherent domains over 50 nm in at least
one direction, as determined by using the Scherrer equa-
tion. No morphological differences have been observed with
modification of temperature for each formation domain,
but synthesis under more acidic conditions promotes
growth of well-faceted plates for m-CPPT β and thicker and
longer needles for t-CPPD.
Several syntheses of pyrophosphate hydrates with the ge-
neral formula M2P2O7·nH2O, in which M is a bivalent
metal, have been reported: these include condensation of
hydrogen phosphate ions HPO42–,[29–32] precipitation pro-
cesses, the use of ion-exchange resins[33,34] and double de-
composition. In these cases, the product was then allowed
to stand for several hours to crystallise into the desired
phase. Double decomposition has been used to form
amorphous and then crystalline pyrophosphate compounds
of manganese pyrophosphate, Mn2P2O7·nH2O,[35] amor-
phous cobalt pyrophosphate, Co2P2O7·nH2O, which was
used as an intermediate for the synthesis of crystalline com-
pounds such as Co2P2O7·6H2O,[36] and calcium pyrophos-
phate (CPP), which was formed as an amorphous hydrated
phase a-CPP and then crystallised into two dimorphs of
Ca2P2O7·2H2O (t-CPPD and m-CPPD) and two dimorphs
of Ca2P2O7·4H2O (m-CPPT α and m-CPPT β).[12,20,23,24]
The coprecipitation of calcium and pyrophosphate ions
at room temperature and without monitored pH leads to
an amorphous phase.[12,20,24] We showed that the amor-
phous phase can also be synthesised by our method within
a wide range of temperatures and pH (from ambient tem-
perature to 90 °C and from pH 5.8 to 7.4) with no evidence
of crystallisation (Figure 1).
Interestingly, this amorphous calcium salt can precipitate
at much higher temperature than amorphous calcium or-
thophosphate or amorphous calcium carbonate, which are
also amorphous calcium salts of biological interest. Unlike
these latter amorphous phases, which may crystallise readily
even at room temperature, a-CPP did not crystallise during
the 45 min of synthesis at 90 °C or if kept in the mother
liquor for over 6 months at room temperature. This stability
could be explained by the flexible structure and probably
the size of the P2O74– anion, which could enhance inhibi-
tion of crystallisation of a-CPP compared to the CO32– or
PO43– anions in calcium carbonate and calcium phosphate
salts, respectively.[24] The highly flexible P–O–P bond has
been reported with angles varying from 123° to 180° in the
solid state.[37]
However, it has been reported that the amorphous phase
then crystallised within one day to one week under specific
conditions into the different crystalline forms already men-
tioned.[12,13,20] Thereby, the published synthesis methods of
crystalline CPP are mostly based on the dissolution of an
intermediate, amorphous CPP (a-CPP) or calcium dihydro-
gen pyrophosphate (CaH2P2O7), followed by crystallisation
into the CPP phase by using different synthesis conditions
(pH temperature, concentration, agitation, time). These
syntheses were performed for more than 24 h and led to
low total reaction yields.[20]
The method we set up for the m-CPPT β and t-CPPD
syntheses used conditions already described to lead to this
phase from a-CPP as intermediate: temperature below
50 °C and pH above 5 for m-CPPT β, and in acidic medium
and the use of a steam bath for t-CPPD.[12,13,20,23] However,
the synthesis described in this study was achieved in one
step within 45 min, as with the other three phases synthe-
sised, and was faster than the 24 h to one week needed for
the previously published methods.
The synthesis method also allowed synthesis of the m-
CPPD phase, a biologically relevant phase that has been
observed in several joints of arthritic patients in addition to
t-CPPD[4] and appears to have greater inflammatory prop-
erties than t-CPPD.[5,6] m-CPPD has been poorly studied
in the literature; the synthesis methods already published
often involve Mg2+ ions or lead to a mixture of m-CPPD
and t-CPPD phases.[12–15,25]
Figure 1 shows that the conditions for m-CPPD synthe-
sis were very narrow: lower pH values and temperatures
during the synthesis lead to the formation of m-CPPT β
instead of the dihydrate and higher pH values and tempera-
tures lead to t-CPPD, as already mentioned.[12] The synthe-
sis conditions of pH 5.8 and 90 °C allowed the formation
of the m-CPPD phase, and the reaction time was fast
enough to avoid the transition into t-CPPD mentioned by
Brown et al.[12] In water, m-CPPD and m-CPPT β were re-
ported to slowly evolve to the t-CPPD phase. However, we
determined that if m-CPPD was kept in the mother liquor
at 50 °C for over 1 month, the as-synthesised m-CPPD
phase does not evolve into t-CPPD.
Interestingly, the synthesis of m-CPPD described in the
present study occurred without the addition of Mg2+ ions
to the solution; however, the nature of the crystals formed
was reported to be highly dependent on the concentration
of Mg2+ ions, which are the main impurity in commercial
calcium salts. The calcium nitrate salt we used contained
less than 100 ppm Mg2+ ions (manufacturer analysis). High
concentrations of magnesium ions are known to favour m-
CPPD formation, as reported by Cheng et al.,[15,38] and
magnesium ions are used for this purpose in the method
developed by Mandel et al.[13] However, pyrophosphate
ions are approximately five times more effective in seques-
tering magnesium ions than calcium ions and could lead to
impurities in the crystals.[39] This point could partially ex-
plain why it is difficult to obtain a pure m-CPPD phase and
why the structure of this phase is still unresolved 50 years
after its first preparation and XRD characterisation.[4]
Thus, we briefly investigated the influence of different pa-
rameters on the synthesis of m-CPPD.
Different molar ratios of calcium/pyrophosphate (from
[Ca2+] = [P2O74–] to [Ca2+] = 4[P2O74–] with [Ca2+] =
150 mmolL–1) were used at fixed pH and temperature cor-
responding to the conditions for the formation of m-CPPD
(pH 5.8 and 90 °C).
A mixture of m-CPPD and t-CPPD appeared at [Ca2+]
= 1.5[P2O74–] and below, and an amorphous phase formed
for [Ca2+] = 3[P2O74–] and above.
It should also be noted that if the calcium solution was
added to the buffered pyrophosphate reagent with [P2O74–]
= 75 mmolL–1, that is, with a large excess of pyrophosphate
ions compared to calcium ions, a phase identified as a
pentacalcium diammonium pyrophosphate hexahydrate,
Ca5(NH4)2(P2O7)3·6H2O, formed.
Physicochemical Characterisation of as-Synthesised Pure
CCP Phases
Four samples, one for each pure CPP phase synthesised
at pH and temperature within their respective domain of
formation, were selected for further characterisation. These
samples correspond to the synthesis conditions reported in
Table 1.
Table 1. Synthesis temperature and pH of the selected samples fur-
ther characterised by powder XRD and FTIR spectroscopy ([Ca2+]
= 2[P2O74–] = 150 mm).
a-CPP m-CPPD β m-CPPD t-CPPD
Temperature [°C] 25 25 90 90
pH 5.8 4.5 5.8 3.6
The crystalline samples selected were identified by pow-
der X-ray diffraction analysis (Figure 2) as m-CPPT β, m-
CPPD and t-CPPD by the characteristic pattern of each
phase according to the published data (Table 2).[13,22,28] A
fourth pattern, including a broad diffuse halo was also ob-
served and is characteristic of an amorphous phase (a-
CPP).
Figure 2. XRD patterns of the hydrated calcium pyrophosphate
phases synthesised.
The pattern obtained for the m-CPPD phase was in good
agreement with the data published by Brown et al. and the
patterns published by Liu et al.[12,19] but did not correspond
to the lattice constant determined by Mandel et al.[13] The
structure of m-CPPD has not been resolved, even though
m-CPPD has been identified in arthritic joints.[5,25]
Rietveld refinements were performed on the X-ray dif-
fraction patterns of the as-synthesised m-CPPD and were
based on the dihydrate pyrophosphate compound cell pa-
rameters from other monoclinic pyrophosphate dihydrate
structures fully identified as Mg2P2O7·2H2O,[30] Co2P2O7·
2H2O,[31] Fe2P2O7·2H2O[32] and Mn2P2O7·2H2O,[35] which
share very similar cell parameters and atomic organisation.
However, no satisfactory cell parameters similar to those
of the X2P2O7·2H2O structures were found from the powder
X-ray diffraction pattern; therefore, the m-CPPD structure
could be significantly different from those of the other dihy-
drate pyrophosphate compounds (Table 2).
Table 2. Unit-cell parameters obtained by Rietveld refinement for the m-CPPT β, t-CPPD and m-CPPD samples compared to the single
crystal data from Balić-Žunić et al. and Mandel.[22,28] Estimated standard deviations are given in parentheses.
Ref. Rp/Rwp a [Å] b [Å] c [Å] α [°] β [°] γ [°]
m-CPPT β refined 0.0614/0.0789 12.288(1) 7.512(1) 10.776(1) 90.00 112.51(1) 90.00
[22] 12.287(6) 7.511(3) 10.775(5) 90.00 112.54(1) 90.00
t-CPPD refined 0.0538/0.0684 7.359(5) 8.279(6) 6.690(5) 102.87(1) 72.73(1) 94.96(1)
[28] 7.365(4) 8.287(4) 6.691(4) 102.96(1) 72.73(1) 95.01(1)
m-CPPD refined 0.0772/0.1020 12.618(1) 9.250(1) 6.760(1) 90.00 104.97(1) 90.00
FTIR and Raman spectroscopy allow clear identification
of pyrophosphate compounds and provide valuable infor-
mation on the confirmation of the pyrophosphate ion.
Thus, thanks to the flexibility of the pyrophosphate anion
in the structure, these methods provide an effective means
to clearly identify calcium pyrophosphate hydrates. Fig-
ures 3 and 4 show FTIR and Raman spectra, respectively,
of the four as-synthesised hydrated CPP phases; the posi-
tions and assignments of the IR and Raman bands for the
three crystalline hydrated CPP phases are reported in
Table 3.
Figure 3. FTIR spectra of the four hydrated calcium pyrophos-
phate phases synthesised. (a) 4000–400 cm–1 domain, (b) 1300–
500 cm–1 domain.
Although Cornilsen predicted 21 Raman and 21 IR
active modes of P2O74– for t-CPPD,[40] these vibrations
could not be separated in the spectra, and the data are dis-
cussed with regard to the vibrational domains of the free
Figure 4. Raman spectra of the four hydrated calcium pyrophos-
phate phases synthesised. (a) 400–4000 cm–1 domain, (b) 500–
1300 cm–1 domain.
ion. Eight P–O stretching modes can be distinguished in
the following order of frequencies and assignments: four
νasPO4  νsPO4  νasPO4  νasPOP  νsPOP (Figures 3, a
and 4). P–O and P–O–P stretching vibration bands were
observed between 1250 and 950 cm–1 and between 950 and
700 cm–1, respectively, in the spectra of t-CPPD, m-CPPT
β and m-CPPD (Table 3).
These P2O74– vibration modes were observed for all three
crystalline samples (t-CPPD, m-CPPT β and m-CPPD) by
IR and/or Raman spectroscopy. The band positions are
somewhat distinct and allowed unambiguous attribution of
the bands for each hydrated CPP phase.
As already noted, the 21 predicted active modes are not
all apparent, although several bands present shoulders. In
particular, the νasPOP vibration in the FTIR spectra seems
to be coupled with another band, and this is especially ap-
parent for m-CPPT β. This band was not observed in the
Raman spectra.
Water O–H vibrations occurred in the 3700–2800 cm–1
region, and there are significant differences between the
spectra of the synthesised pure CPP phases. This region of
the m-CPPD spectrum seemed closer to the spectrum of
m-CPPT β, a tetrahydrate with layers composed of water
molecules, than to that of t-CPPD, another dihydrate. A
weak broad adsorption band also appeared in the 2400–
1950 cm–1 range. In the absence of H3O+ ions and P–O–H
Table 3. Vibrational band position [cm–1] assignments and calcu-
lated P–O bond lengths for m-CPPD, t-CPPD and m-CPPT β.
groups in the crystal, this band was presumed to corre-
spond to composite vibration of water molecules (δ +
ω)OH.[41]
The spectroscopic data also allow direct information
about the P2O74– configuration to be obtained, and espe-
cially the P–O–P bond angle, as proposed by Rulmont et
al.[37] In t-CPPD and m-CPPT β, the P2O74– anions have a
bent P–O–P angle and an eclipsed configuration. In par-
ticular, the P–O–P angle has been reported as 123.1° for t-
CPPD and 134.1° for m-CPPT β, both in the dichromate
configuration.[22,28] The P2O74– anion could be considered
as a three-body system, mainly by disregarding couplings
between the vibrations of the P–O–P bridge and those of
external PO3 groups and the influence of Ca on the vi-
brational frequencies of the anion. Within this approxi-
mation, the stretching frequencies observed by IR and Ra-
man spectroscopy depend on the P–O–P angle θ and the
force constant k of the P–O bond.
Lazarev suggested an empirical relationship between the
P–O–P angle θ and a quantity Δ [Equation (2)] that elimi-
nates the contribution of the force constant k.[42]
Δ = (νasPOP – νsPOP)/(νasPOP + νsPOP) = f(θ) (2)
The Lazarev relationship has been applied to pyrosil-
icates, pyrogermanates and pyrophosphates and was satis-
factorily obeyed by a large majority of compounds, al-
though a few of them exhibited a significant deviation from
the main curve.[37] In those cases, the two approximations
mentioned above could explain the differences observed.
However, the relationship seems to be confirmed and is lin-
ear for pyrophosphate compounds with dichromate struc-
ture.
The Lazarev relationship was applied to m-CPPD with
100Δ = 11.54, and a θ angle of 133.6° was determined from
the plot published by Rulmont et al.[37] This value was com-
pared to those of the other calcium pyrophosphate com-
pounds α-Ca2P2O7, β-Ca2P2O7, m-CPPT β and t-CPPD,
which are 130.0, 130.5 and 137.8 (two sites), 134.1 and 123°,
respectively. The configuration of the P2O74– anion in m-
CPPD was determined to be closer to those of anhydrous
or tetrahydrated compounds than to that of the other di-
hydrate, t-CPPD, or even other types of dihydrates such as
Mn2P2O7·2H2O, Fe2P2O7·2H2O, Co2P2O7·2H2O and
Mg2P2O7·2H2O (127.5, 125.9, 126.2 and 125.7°, respec-
tively), all of which exhibited much lower values for the P–
O–P angle.[30–32,35]
Differences between pyrophosphate phase structures
have already been reported for anhydrous compounds by
Brown and Calvo.[43] Crystals of the composition X2Y2O7
(Y = Si, P, As, Ge) with an ionic radius for X of less than
0.97 Å (X = Mg, Mn, Fe, Co, Ni, Cu, Zn) are isostructural
with thortveitite (Sc2Si2O7) with X–O–X bond angles of
140–180°, an O–Y···Y–O torsion angle of 60° (staggered
conformation), and the YO4 tetrahedra shows a very low
degree of distortion, However, those in which X has an
ionic radius greater than 0.97 Å (X = Ca, Sr, Ba) usually
crystallise with a dichromate structure with a Y–O–Y angle
of ca. 120–130°, an O–Y···Y–O torsion angle of 0–30°
(eclipsed conformation) and distorted YO4 tetrahedra.[21]
Unlike the corresponding anhydrous compounds,
Mn2P2O7·2H2O, Fe2P2O7·2H2O, Co2P2O7·2H2O and
Mg2P2O7·2H2O present a dichromate structure with O–
P···P–O torsion angles and P–O–P angles between those of
t-CPPD and α-Ca2P2O7.
Moreover, Mandel correlated this value of the θ angle to
a deformed tetrahedra and a P–O distance in the bridge
between 1.61 and 1.63 Å.[28] According to Cruickshank,
this relationship is based on the dπ–pπ overlap in the P–O
bonds.[44] A P–O–P angle of ca. 130° would degrade dπ–pπ
overlap in the P–O bonds in the bridge and, therefore, result
in a larger P–O distance.
For an angle of ca. 180°, the P–O bonds receive some π
character from the p orbital in the P–O–P plane as well as
from the p orbital perpendicular to the plane, and the bond
length then decreases. At the P–O–P angle limit of 180°,
both p orbitals on the oxygen atom perpendicular to the P–
O–P line would share fully in the two π systems. This case
corresponds to the thortveitite Sc2Si2O7 structure, in which
the PO4 tetrahedra show a very low degree of distortion, as
in the β-Mg2P2O7 structure.
For an angle of ca. 130°, the π character decreases and
the bond length is supposed to increase.[45]
A comparison of the Raman and IR bands of the PO3
deformation modes between 700 and 400 cm–1 and the
stretching modes between 1250 and 950 cm–1 could also be
used to determine if the pyrophosphate compounds have a
centrosymmetric structure. The coincidence of the Raman
and IR bands in this domain confirms that the structure is
not a centrosymmetric thortveitite structure.
Chemical analyses were performed to determine the
composition of the as-synthesised CPP phases. We first con-
sidered that the conditions of synthesis used in these prepa-
rations of calcium pyrophosphate phases could lead to hy-
drolysis of pyrophosphate anions into two hydrogen phos-
phate anions [Equation (3)].
P2O74– + H2O h 2HPO42– (3)
This hydrolysis reaction has been reported to occur
through two different processes: as an intracrystalline pro-
cess referred to as internal hydrolysis and a process in solu-
tion referred to as external hydrolysis.[24]
Internal hydrolysis of pyrophosphate was observed in
amorphous calcium pyrophosphate at a moderate tempera-
ture of 37 °C. Water molecules contained in the bulk solid
react with nearby pyrophosphate molecules to form small
amounts of phosphate anions.[24] However, the phenome-
non is negligible under 140 °C.
At lower temperatures, a homogeneous hydrolysis of
P2O74– ions in solution occurs and is favoured by acidic
pH. These reaction conditions were implemented for the
chemical analysis of P2O74– ions in the as-synthesised CPP
samples (see Experimental Section). Significant amounts of
orthophosphate anions could be produced by this process
during the synthesis depending on the pH and temperature
used.[46]
Phosphorus titrations, of orthophosphate (PO43– and
HPO42–) and pyrophosphate (P2O74–) ions, were performed
to assess the percentage of pyrophosphate hydrolysed dur-
ing the synthesis (Table 4). The results indicate that pyro-
phosphate hydrolysis is very limited: ca. 2% of the P2O74–
ions of each crystalline CPP phase synthesised were titrated
as hydrolysed. This hydrolysis could have occurred during
the preparation of the sample for titration or during the
synthesis. In any case, the quantity of orthophosphate ions
detected corresponds to the detection limit of the method.
Table 4. Phosphorus (as P2O74–, PO43– or HPO42– ions) and cal-
cium contents in the four synthesised hydrated CPP phases deter-
mined by chemical analyses.
P as P2O74– P as PO43– or Ca as Ca2+ Ca/P[wt.-%] HPO42– [wt.-%] [wt.-%]
t-CPPD 21.2 0.29 27.6 1.01
m-CPPD 21.2 0.57 27.6 1.01
m-CPPT β 19.1 0.23 24.6 1.00
a-CPP 19.5 0.86 25.2 1.00
The present synthesis conditions of temperature and pH
do not allow significant hydrolysis of pyrophosphate
anions, even under the more extreme conditions (acidic pH
and high temperature). The significantly higher concentra-
tion of orthophosphate ions in the a-CPP sample, synthe-
sised at pH 5.8 and 25 °C, indicated either a propensity of
the noncrystalline structure to incorporate phosphate ions
or an easier hydrolysis of pyrophosphate ions in this com-
pound after its formation.
The calcium to phosphorus ratio is commonly used to
partially identify phases for calcium phosphate compounds
and quantify calcium deficiency. Calcium titrations were
performed and the results exhibited a characteristic Ca/P
ratio of 1 for all calcium pyrophosphate compounds synthe-
sised (Table 4). This indicates that compounds show no cal-
cium deficiency, which could have happened, for example,
if protonated pyrophosphate species were present in the
precipitates. Moreover, the titration of the crystalline com-
pounds was consistent with the expected water content in
the crystalline phases: two H2O molecules for m-CPPD and
t-CPPD and four H2O molecules for m-CPPT β.
Thermogravimetric analyses were performed to study the
evolution of the calcium pyrophosphate hydrates up to
500 °C (Figure 5). The weight loss in the crystalline phases
occurred in three steps for the dihydrates and four steps for
m-CPPT β.
Figure 5. (a) TGA and (b) DTA curves of the pure hydrated cal-
cium pyrophosphate phases synthesised.
Weight losses corresponding to approximately half a
H2O molecule (0.45 H2O) and one H2O molecule (1.11
H2O) were observed for t-CPPD and m-CPPD, respectively,
between 30 and 275 °C. Two steps were noted in this range,
and they were correlated to wide endothermic peaks on the
differential thermal analysis diagram for both compounds.
A third step occurred in the range 300–400 °C for t-CPPD
and 275–350 °C for m-CPPD, and this led to a dehydrated
phase β-Ca2P2O7. DTA diagrams indicated that these losses
corresponded to two endothermic peaks at 315 and 330 °C
for t-CPPD and 300 and 305 °C for m-CPPD.
The thermogravimetric analysis of m-CPPT β has been
described previously, and there is an initial weight loss of
one H2O molecule (0.90 H2O) at ca. 30 °C owing to the
instability of the structural water in the m-CPPT β
phase.[22,27] This loss at low temperature was detected dur-
ing the preliminary plateau of the thermogravimetric analy-
sis at ca. 30 °C. The weight loss between 80 and 110 °C
corresponds to two H2O molecules, whereas the one be-
tween 300 and 450 °C corresponds to one H2O molecule
and leads to the anhydrous β-Ca2P2O7. However, the dif-
ferent mechanisms were not described in the previous stud-
ies.
These dehydration processes are in good agreement with
the structure of the m-CPPT β phase, which has three dif-
ferent coordinations of H2O molecules. The slight slope be-
tween 110 and 300 °C was decomposed by DTA into two
exothermic peaks, which were elucidated by FTIR analysis
as an internal hydrolysis described by Equation (3) and the
formation of anhydrous dicalcium phosphate or monetite
[Equation (4)], identified by XRD and FTIR spectroscopy.
Ca2P2O7·H2O 2CaHPO4 (4)
This reaction was followed by a final loss of a water mo-
lecule and reconstitution of the P2O74– anions to form to
the anhydrous phase β-Ca2P2O7 [Equation (5)].
2CaHPO4 H2O + Ca2P2O7 (5)
The reverse reaction occurred at ca. 400 °C and led to
the anhydrous phase β-Ca2P2O7. This mechanism of de-
hydration was observed only with the m-CPPT β phase.
The amorphous phase exhibited a continuous weight loss
from 30 to 500 °C with a total loss of 3.87 H2O molecules.
This hydration is consistent with the values in the range
3.8–4.2 reported by Slater et al., which varied slightly from
sample to sample.[24]
Exothermic peaks appeared between 110 and 250 °C for
the DTA of the amorphous phase, in the same way as m-
CPPT β and at the same temperature at which m-CPPD
and t-CPPD experienced their first step of dehydration. Ac-
cording to the phenomenon observed with the m-CPPT β
phase, the exothermic peak could correspond to a partial
internal hydrolysis at ca. 220 °C, as reported by Slater et
al.[24]
The total weight losses are reported in Table 5 and corre-
spond to the hydration expected for the crystalline phases.
Figure 6 shows the different crystal or particle morpho-
logies of each pure CPP phase as observed by SEM. The
crystals of the dihydrated phases were acicular with a large
heterogeneity in size. The t-CPPD crystals seemed larger
than the m-CPPD crystals, in agreement with former obser-
vations.[12,13]
The measured sizes were within the range 1–30 μm for t-
CPPD with a maximum width of 5 μm and 1–25 μm for m-
Table 5. Total weight loss in the pure hydrated CPP phases synthe-
sised.
t-CPPD m-CPPD m-CPPT β[a] a-CPP[a]
H2O per unit 2.12 2.14 3.73 3.87
[a] Including loss of water during the preliminary plateau at 30 °C:
a-CPP 0.31 H2O and m-CPPT β 0.90 H2O.
Figure 6. SEM micrographs of the four synthesised hydrated cal-
cium pyrophosphate phases. (a) t-CPPD, (b) m-CPPD, (c) m-CPPT
β and (d) a-CPP.
CPPD with a maximum width of 1 μm. The bundle mor-
phologies, which correspond to category two spherulites,
are supposed to be caused by growth from a nucleus, poss-
ibly a single acicular crystal formed during the first period
of the synthesis.[47]
m-CPPT β has a faceted plate morphology with a di-
ameter of up to 20 μm. Balić-Žunić et al.[22] suggested that
this morphology was related to the layered structure of this
compound.
At higher pH, the m-CPPT β crystals formed had a di-
ameter of ca. 5 μm with irregular shape, and the t-CPPD
crystals showed an acicular shape, similar to that of m-
CPPD, with fine needles of around 20 μm length. The a-
CPP sample contained round particles with diameters of ca.
100 nm.
It has been reported that CPP crystals can have a wide
range of sizes and could potentially present different mor-
phologies. Christoffersen et al.[17,18,48] have studied the crys-
tal growth and dissolution of t-CPPD and it presents two
different morphologies with different dissolution kinetics.
This variety of morphologies could partially explain the dif-
ferent inflammatory potentials between the phases and be-
tween samples of a phase.
The specific surface area (SSA) of the four hydrated CPP
phases synthesised by the method we set up were deter-
mined as 1.3 m2 g–1 for t-CPPD, 5.0 m2 g–1 for m-CPPD,
4.8 m2 g–1 for m-CPPT β and 25.7 m2 g–1 for a-CPP. The
SSA values are low for the three crystalline phases, as ex-
pected, considering their crystal morphology and size (Fig-
ure 6). These values are consistent with data already pub-
lished.[5,14]
In addition to phase structure and morphology, surface
area has been suggested as an important factor in the pro-
posed mechanism of inflammation based on the rupture of
lysosome phospholipid membranes by pyrophosphate spe-
cies on the surface of the crystals.[3–5]
Conclusions
The protocol we established allows a fast one-step syn-
thesis of four phases of CPP of biological interest by moni-
toring the pH and temperature during the synthesis. t-
CPPD and m-CPPD, the two phases detected in the joints
of arthritic patients, and m-CPPT β and a-CPP, in vitro
precursors of the dihydrates, were obtained without inter-
mediates.
The in vitro study of the formation of synthetic and well-
characterised hydrated calcium pyrophosphate phases avail-
able in large amounts could allow a better understanding
of the presence of these phases in vivo in joints and contrib-
ute to the clarification of the mechanism by which CPP
crystals form in vitro and in vivo. Moreover, fine characteri-
sation of the different synthetic CPP phases could improve
their detection in patients suffering from calcium salt crys-
tal diseases.
Experimental Section
General: The hydrated calcium pyrophosphates were synthesised by
double decomposition of a potassium pyrophosphate solution and
a calcium nitrate solution mixed into a buffer solution at a con-
trolled temperature.
Materials: Anhydrous tetrapotassium pyrophosphate (K4P2O7) was
prepared by heating dipotassium phosphate (K2HPO4, VWR, Ana-
lytical reagent, 100 g) at 400 °C for 3 h in a muffle furnace.
Anhydrous tetrapotassium pyrophosphate was analysed by XRD
and FTIR spectroscopy. No detectable amount of dipotassium
phosphate was observed, and the FTIR spectrum showed the char-
acteristic vibrational modes of P2O74– ions (data not presented).
Calcium nitrate tetrahydrate salt [Ca(NO3)2·4H2O, Carlo Erba,
ACS], ammonia solution (NH4OH, VWR, 30%) and acetic acid
(C2H4O2, VWR, NormaPur) were used as received without further
purification.
The reagents were stored in a dry place without evidence of degra-
dation after 6 months.
All solutions were prepared with deionised water.
Syntheses: A buffer solution was prepared by adding acetic acid
(12 mL) and a variable amount of ammonia solution to water
(400 mL). The pH was chosen in a range from 3.6 to 5.8. The
solution was stirred and heated to a chosen temperature in the
range 25–90 °C (2 °C).
Calcium and pyrophosphate reagent solutions were prepared sepa-
rately by dissolving Ca(NO3)2·4H2O (7.16 g, 3.03 10–2 mol) and
K4P2O7 (5.00 g, 1.51 10–2 mol) in deionised water (200 mL). The
reagent solutions were then added simultaneously into the buffer
solution by using a peristaltic pump at a constant volumetric flow
rate (4.5 mL min–1) to maintain the stoichiometry of the system.
The first white precipitate was observed from 3 to 10 min after the
beginning of the addition of the reagent solution, depending on the
synthesis conditions. The complete addition of the reagent solu-
tions lasted 45 min. After the addition of the reagent solutions was
completed, the precipitate formed was left in the mother solution
for 10 min at the precipitation temperature.
Filtration was performed by using a Büchner funnel. The precipi-
tate was then washed three times with deionised water and finally
dried in an oven at 37 °C overnight. The powder samples were kept
at room temperature in sealed vials. No evidence of phase alter-
ation was observed after more than 1 year of storage under these
conditions. The yield for this synthesis method was above 90% for
the crystalline phases (m-CPPD 4.08 g, t-CPPD 4.13 g, m-CPPT β
4.61 g) and above 85% for a-CPP (4.21 g).
The influence of the concentration of the reagents was studied by
varying the amount of potassium pyrophosphate in the reagent
solution from 2.5 to 10.0 g in water (200 mL, 37.5 to 150.0 mm,
respectively).
Characterisation of Products: Powder X-ray diffraction (XRD)
measurements were performed with a Seifert XRD-3000 TT dif-
fractometer with Cu-Kα radiation (Cu-Kα1 λ = 1.54060 Å and Cu-
Kα2 λ = 1.54443 Å) and equipped with a graphite monochromator.
The XRD patterns were obtained in the 2θ range 2–70° with a step
size of 0.02° and a scan step time of 16 s at 298 K.
The crystallographic lattice constants were determined by the
Jana2006 software (01/07/2011 version).[49] A pseudo-Voigt shape
function was assumed and the background was determined man-
ually. The refinement of the parameters was performed in the order
scale factor, zero shift, cell parameters, profile parameter and asym-
metry parameter. The total number of variables refined was nine.
The FTIR experiments were performed with a Thermo Nicolet
5700 FTIR spectrometer. The spectra were recorded in the 4000–
400 cm–1 wavelength range with a 64 scan accumulation and 4 cm–1
resolution with powder samples in KBr pellets (2 mg of sample in
300 mg of KBr). The peak positions were determined by using sec-
ond derivation achieved by the Savitzky–Golay routine with a nine-
point third-order polynomial smoothing.[50]
Raman microspectroscopy analysis was performed with a Horiba
Jobin Yvon Labram HR800 confocal microspectrometer equipped
with an AR-diode laser (λ = 532 nm) over a wavenumber range of
55–1750 cm–1.
Thermogravimetric analyses (TGA-DTA) were performed with a
Setaram Instrumentation Setsys evolution system from 30 to
500 °C at a heating rate of 5 °C per minute.
Scanning electron microscopy (SEM) observations were performed
with a Leo 435 VP microscope. The accelerating voltage was fixed
at 7 kV. Samples were silver plated before observation.
A standard spectrophotometric determination of the yellow phos-
phovanadomolybdic acid complex was used to determine phos-
phate concentration. Absorption measurements were performed
with a Hitachi U-1100 spectrometer set at 460 nm. The pyrophos-
phate concentrations were determined after hydrolysis of the pyro-
phosphate ions into phosphate ions. The samples were hydrolysed
at 100 °C in acidic medium for 1 hour, and then the phosphate ions
were titrated as described above.
The calcium concentrations were determined by complexometry
with ethylenediaminetetraacetic acid (EDTA).[51] The calcium and
phosphate titrations had estimated standard deviations equivalent
to 1% of the reading.
The specific surface areas of the samples were evaluated with a
Quantachrome Instruments Monosorb Nova 1000 by using the
Brunauer–Emmett–Teller method (nitrogen adsorption) with an es-
timated standard deviation of 0.5 m2 g–1.
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